Health economic Impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland;Koszty leczenia zakażeń spowodowanych wirusami oddechowymi oraz zapaleń płuc w populacji osób starszych w Polsce

Polski Merkuriusz Lekarski

Volumn 29, Issue 169, 2010, Pages 37-40

  Jahnz Róźyk, Karina ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Costs of disease study; Influenza; Pneumonia; Streptococcus pneumoniae

Indexed keywords

INFLUENZA VACCINE;

AGED; AMBULATORY CARE; ARTICLE; COST OF ILLNESS; ECONOMICS; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INFLUENZA; POLAND; RETROSPECTIVE STUDY; VIRUS PNEUMONIA;

AGED; AMBULATORY CARE; COST OF ILLNESS; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PNEUMONIA, VIRAL; POLAND; RETROSPECTIVE STUDIES;

EID: 77955952017     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. 1. Berger M.L., Bingefors K., Hedblom E.: Health Care Costs, Quality and Outcomes. ISPOR and ISPOR Lexicon, USA, 2003.
2. 2. Brundage J.F.: Interactions between influenza and bacterial respiratory pathogens; implication for pandemic preparedness. Lancet, 2006, 6, 303-312.
3. 3. Brydak L.: Grypa i jej profilaktyka. Termedia, Poznań 2004.
4. Cai L., Uchiyama H., Yonagisava S., Kamae J.: Cost-effectiveness analysis of influenza and pneumococcal vaccination among elederly poeple in Japan. Kobe J. Med. Sci., 2006, 52, 4, 97-109.
5. Centers for Disease Control and Prevention: Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza-United States, May-August 2009.
6. Dominguez A., Salleras L., Fedson D. i wsp.: Effectiveness of pneumococcal poly sachardide vaccine for elderly people in Catalonia, Spain: a case control study. Clin. Inf. Dis., 2005, 40, 1250-1257.
7. Fedson D.S., Scott J.A.G.: The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known. Vaccine, 1999, 17, supl. 1, S11-18.
8. File T.M., Marrie T.J.: Burden of community acquired pneumonia in North American adults. Postgrad. Med., 2010, 122, 2, 130-141.
9. Hryniewicz W.: Rekomendacje postȩpowania w pozaszpitalnych zakażeniach układu oddechowego. Warszawa 2010.
10. Jahnz-Różyk K., Targowski T., From S.: Koszty leczenia zaostrzeń POChP w warunkach ambulatoryjnych i szpitalnych w 2007 roku. Pol. Merk. Lek., 2009, XXVI, 153, 208-215.
11. Jokinen C, Heiskanen L., Juvonen H. i wsp.: Incidence of community acquired pneumonia in the populations of four municipalities in eastern Finland. Am. J. Epidemiol., 1993, 137, 977-988.
12. Kaplan V., Angus D., Griffin J. i wsp.: Hospitalized CAP in the elderly; age and sex-related patterns of care and outcome in United States. Am. J. Respir. Crit. Care Med., 2002, 165, 766-772.
13. Maruyama T., Gabazza E.C., Morser J. i wsp.: Community-acquired pneumonia and nursing Home-acquired pneumonia in very elderly patients. Respir. Med., 2010, 104,4, 584-592.
14. Maruyama T., Taguchi O., Niederman M. i wsp.: Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomized and placebo controlled trial. BMJ, 2010, 340, c1004 (on line).
15. Paladino J.A., Adelman M.H., Schentag J.J. i wsp.: Direct costs in patients hospitalized with CAP after non response to outpatient treatment with macrolide antibacterials in US. Pharmacoeconomics, 2007, 25, 8, 677-683.
16. Pallares R.: Pneumococcus. In: A guide to infection control in the hospital. Wenzel, Bearman, Brewer, Butzler (red.), Boston, USA, 2008.
17. Ruiz-Gonzalez A., Falguera M., Nogues A. i wsp.: Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community- acquired pneumonia. Am. J. Med. 1999, 106, 385-390.
18. Thompson W., Shay D.K., Weintraub E. i wsp.: Mortality associated with influenza and respiratory syncytial virus in United States. JAMA, 2003, 289, 179-186.
19. Woo H., Hui E., Fos A. i wsp.: Influenza-like ilness in residential care homes: a study of incidence, aetiological agents, natural history and health recource utilisation. Thorax, 2008, 63, 8, 690-697. (Pubitemid 36068705)
20. Woodhead M. i wsp.: Lower respiratory tract infection guidelines. ERS Task Force in Collaboration with ESCMID. Eur. Respr. J., 2005, 26, 1138-1180.